| Literature DB >> 26149887 |
Preetha Rajaraman1, Benjamin O Anderson2, Partha Basu3, Jerome L Belinson4, Anil D' Cruz5, Preet K Dhillon6, Prakash Gupta7, Tenkasi S Jawahar8, Niranjan Joshi9, Uma Kailash10, Sharon Kapambwe11, Vishwa Mohan Katoch8, Suneeta Krishnan12, Dharitri Panda10, R Sankaranarayanan13, Jerard M Selvam14, Keerti V Shah15, Surendra Shastri16, Krithiga Shridhar6, Maqsood Siddiqi17, Sudha Sivaram18, Tulika Seth19, Anurag Srivastava19, Edward Trimble18, Ravi Mehrotra10.
Abstract
Cancers of the breast, uterine cervix, and lip or oral cavity are three of the most common malignancies in India. Together, they account for about 34% of more than 1 million individuals diagnosed with cancer in India each year. At each of these cancer sites, tumours are detectable at early stages when they are most likely to be cured with standard treatment protocols. Recognising the key role that effective early detection and screening programmes could have in reducing the cancer burden, the Indian Institute for Cytology and Preventive Oncology, in collaboration with the US National Cancer Institute Center for Global Health, held a workshop to summarise feasible options and relevant evidence for screening and early detection of common cancers in India. The evidence-based recommendations provided in this Review are intended to act as a guide for policy makers, clinicians, and public health practitioners who are developing and implementing strategies in cancer control for the three most common cancers in India.Entities:
Mesh:
Year: 2015 PMID: 26149887 DOI: 10.1016/S1470-2045(15)00078-9
Source DB: PubMed Journal: Lancet Oncol ISSN: 1470-2045 Impact factor: 41.316